- Home
- PLX vs PCQ Comparison
PLX vs PCQ Comparison
Compare PLX & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- PCQ
- Stock Information
- Founded
- PLX 1993
- PCQ 2001
- Country
- PLX Israel
- PCQ United States
- Employees
- PLX N/A
- PCQ N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- PCQ Investment Managers
- Sector
- PLX Health Care
- PCQ Finance
- Exchange
- PLX Nasdaq
- PCQ Nasdaq
- Market Cap
- PLX 160.2M
- PCQ 169.3M
- IPO Year
- PLX 1998
- PCQ N/A
- Fundamental
- Price
- PLX $2.33
- PCQ $8.91
- Analyst Decision
- PLX
- PCQ
- Analyst Count
- PLX 0
- PCQ 0
- Target Price
- PLX N/A
- PCQ N/A
- AVG Volume (30 Days)
- PLX 553.9K
- PCQ 69.6K
- Earning Date
- PLX 03-13-2025
- PCQ 01-01-0001
- Dividend Yield
- PLX N/A
- PCQ 4.63%
- EPS Growth
- PLX N/A
- PCQ N/A
- EPS
- PLX N/A
- PCQ N/A
- Revenue
- PLX $45,667,000.00
- PCQ N/A
- Revenue This Year
- PLX N/A
- PCQ N/A
- Revenue Next Year
- PLX $90.00
- PCQ N/A
- P/E Ratio
- PLX N/A
- PCQ N/A
- Revenue Growth
- PLX N/A
- PCQ N/A
- 52 Week Low
- PLX $0.82
- PCQ $8.19
- 52 Week High
- PLX $2.36
- PCQ $10.50
- Technical
- Relative Strength Index (RSI)
- PLX 78.72
- PCQ 36.61
- Support Level
- PLX $2.11
- PCQ $8.81
- Resistance Level
- PLX $2.36
- PCQ $8.97
- Average True Range (ATR)
- PLX 0.12
- PCQ 0.12
- MACD
- PLX 0.00
- PCQ 0.01
- Stochastic Oscillator
- PLX 94.23
- PCQ 31.13
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About PCQ PIMCO California Municipal Income Fund
PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.